Helicobacter pylori colonization does not influence the syptomatic response to prokinetic agents in patients with functional dyspepsia

Journal of Gastroenterology and Hepatology (Australia)

Volumn 13, Issue 5, 1998, Pages 500-504

  Lu, Ching Liang ^b   Chang, Full Young ^a   Chen, Tseng Shing ^b   Chen, Chih Yen ^b   Jiun, Kang Lih ^b   Lee, Shou Dong ^b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NONE

Author keywords

Functional dyspepsia; Helicobacter pylori; Pancreatic enzmes; Prokinetics

Indexed keywords

METOCLOPRAMIDE; PANCREAS ENZYME; PASPERTASE; PROKINETIC AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DYSPEPSIA; EPIGASTRIC PAIN; FEMALE; HEARTBURN; HELICOBACTER PYLORI; HUMAN; MALE; NAUSEA; PRIORITY JOURNAL; SCORING SYSTEM; TAIWAN;

EID: 0031862442     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1998.tb00676.x     Document Type: Article

References (39)

1. Knill-Jones RP. Geographic differences in the prevalence of dyspepsia. Scand. J. Gastroenterol. 1991; 26 (Suppl. 182): 17-24.
2. Colin-Jones DG. Management of dyspepsia: Report of a working party. Lancet 1988; 1: 576-9.
3. Talley NJ, Colin-Jones DG, Koch KL, Koch M, Nyren O, Stanghellini V. Functional dyspepsia: A classification with guidelines for diagnosis and management. Gastroenterol. Int. 1991; 4: 145-60.
4. Rokkas T, Pursey C, Uzoechina E et al. Campylobacter pylori and non-ulcer dyspepsia. Am. J. Gastroenterol. 1987; 82: 1149-52.
5. Rauws EA, Langenberg W, Houthoff HJ, Zanen HC,Tygat GN. Campylobacter pyloridis-associated chronic active antral gastritis. Gastroenterology 1988; 94: 33-40.
6. Strauss RM,WangTC, Kelsey PB et al. Association of Helicobacter pylori infection with dyspeptic symptoms in patients undergoing gastroduodenoscopy. Am. J. Med. 1990; 89: 464-9.
7. Bernersen B, Johnsen R, Bostad L, Straume B, Sommer AI, Burhol PG. Is Helicobacter pylori the cause of dyspepsia? BMJ 1992; 304: 1276-9.
8. Holtmann G, Goebell H, Holtmann M, Talley NJ. Gastrointestinal symptoms in healthy blood donors: Pattern of symptoms and Helicobacter pylori seroprevalence. Dig. Dis. Sci. 1994; 39: 1090-8.
9. Katelaris PH,Tippett GHK, Norbu P, Lowe DG, Brennan R, Farthing MJ. Dyspepsia, Helicobacter pylori, and peptic ulcer in a randomly selected population in India. Gut 1992; 33: 1462-6.
10. Ching CK, Lam SK. Nonulcer dyspepsia: Association with chronic Helicobacter pylori infection-related gastritis. J. Clin. Gastroenterol. 1995; 21 (Suppl. 1): S140-5.
11. Rokkas T, Pursey C, Uzoechina E et al. Non-ulcer dyspepsia and short term De-Nol therapy: A placebo trial with particular reference to the role of Campylobacter pylori. Gut 1988; 29: 1386-91.
12. Lambert JR, Dunn K, Borromeo M, Korman MG, Hansky J. Campylobacter pylori: A role in non-ulcer dyspepsia. Scand. J. Gastroenterol. 1989; 234 (S160): 7-13.
13. Goh KL, Parasakthi N, Peh SC, Wong NW, Lo YL, Puthucheary SD. Helicobacter pylori infection and nonulcer dyspepsia: The effect of treatment with colloidal bismuth subcitrate. Scand. J. Gastroenterol. 1991; 26: 1123-31.
14. Sheu BS, Lin CY, Lin XZ, Shiesh SC,Yang HB, Chen CY. Long-term outcome of triple therapy in Helicobacter pylori-related nonulcer dyspepsia: A prospective controlled assessment. Am. J. Gastroenterol. 1996; 91: 441-7.
15. Elta GH, Scheiman JM, Barnett JL et al. Long-term follow up of Helicobacter pylori treatment in non-ulcer dyspepsia patients. Am. J. Gastroenterol. 1995; 90: 1089-93.
16. Kang JY, Tay HH, Wee A, Guan R, Math MV, Yap I. Effect of colloidal bismuth subcitrate on symptoms and gastric histology in non-ulcer dyspepsia. A double-blind, placebo-controlled study. Gut 1990; 31: 476-80.
17. Glupczynski Y, Burette A, Labbe M, Deprez C, Reuck MD, Deltenre M. Campylobacter pylori-associated gastritis: A double-blind, placebo-controlled trial with amoxicillin. Am. J. Gastroenterol. 1988; 83: 365-72.
18. Patchett S, Beattie S, Leen E, Keanc C, O'Marain C. Eradicating Helicobacter pylori and symptoms of non-ulcer dyspepsia. BMJ 1991; 303: 1238-40.
19. Johnson AG. Controlled trial of metoclopramide in the treatment of flatulent dyspepsia. BMJ 1971; 2: 25-6.
20. Perkel MS, Moore C, Hersh T, Davidson ED. Metoclopramide therapy in patients with delayed gastric emptying: A randomized, double blind study. Dig. Dis. Sci. 1979; 24: 662-6.
21. Fumagalli I, Hammer B. Cisapride versus metoclopramide in the treatment of functional dyspepsia. A double-blind comparative trial. Scand. J. Gastroenterol. 1994; 29: 33-7.
22. Kleveland PM, Johannessen T, Kristensen P et al. Effect of pancreatic enzymes in non-ulcer dyspepsia. A pilot study. Scand. J. Gastroenterol. 1990; 25: 298-301.
23. Veldhuyzen van Zanten SJO, Cleary C, Talley NJ et al. Drug treatment of functional dyspepsia: A systemic analysis of trial methodology with recommendations for design of future trials. Am. J. Gastroenterol. 1996; 91: 660-73.
24. Lai KH, Chang FY, Tsay SH et al. Medical treatment of duodenal ulcer: Acid inhibition or Helicobacter pylon eradication? J. Gastroenterol. Hepatol. 1991; 6: 141 -4.
25. Marshall BJ, McGeche DB, Roger PA, Glancy RJ. Pyloric Campylobacter infection and gastroduodenal disease. Med. J. Aust. 1985; 142: 439-44.
26. Chang CS, Chen GH, Kao CH, Wang SJ, Peng SN, Huang CK. The effect of Helicobacter pylori infection on gastric emptying of digestible and indigestible solids in patients with nonulcer dyspepsia. Am. J. Gastroenterol. 1996; 91: 474-9.
27. Lai ST, Fung KP, Ng FH, Lee KC. A quantitative analysis of symptoms of non-ulcer dyspepsia as related to age, pathology, and Helicobacter infection. Scand. J. Gastroenterol. 1996; 31: 1078-82.
28. Frommer DJ, Carrick J, Lee A, Hazell SL. Acute presentation of Campylobacter pylori gastritis. Am. J. Gastroenterol. 1988; 83: 1168-71.
29. Anderson L, Elsborg L, Justesen T. Campylobacter pylori in peptic ulcer disease. III. Symptoms and paraclinical and epidemiologic findings. Scand. J. Gastroenterol. 1988; 23: 347-50.
30. Loffeld R, Adang R. Computerized history taking for the assessment of Helicobacter pylori in non-ulcer dyspepsia. Rev. Esp. Enferm. Dig. 1990; 70S: 70-1.
31. LiYY, Hu PJ, Du GG, Hazell SL. The prevalence of Helicobacter pylori infection in the People's Republic of China. Am. J. Gastroenterol. 1991; 86: 446-9.
32. Talley NJ. A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia. Gastroenterology 1994; 106: 1174-83.
33. McCarthy C, Stephen S, Collins RM, Beattie S, Keane C, O'Morain C. Long-term prospective study of Helicobacter pylori in nonulcer dyspepsia. Dig. Dis. Sci. 1995; 40: 114-9.
34. Gilvarry J, Buckley MJM, Beattie S, Hamilton H, O'Morain CA. Eradication of Helicobacter pylori affects symptoms in non-ulcer dyspepsia. Scand. J. Gastroenterol. 1997; 32: 535-40.
35. Malagelada JR, Stanghellini V. Manometric evaluation of functional upper gut symptoms. Gastroenterology 1985; 88: 1223-31.
36. Camilleri M, Malagelada JR, Kao PC, Zinsmeister AR. Gastric and autonomic responses to stress in functional dyspepsia. Dig. Dis. Sci. 1986; 31: 1169-77.
37. Kerlin P. Postprandial hypomotility in patients with idiopathic nausea and vomiting. Gut 1989; 30: 54-9.
38. Rees WDW, Miller LJ, Malagelada JR. Dyspepsia, antral motor dysfunction, and gastric stasis of solids. Gastroenterology 1980; 78: 360-5.
39. Malfertheiner P, Dominguez-Munoz JE. Effect of exogenous enzymes on gastrointestinal and pancreatic hormone release and gastrointestinal motility. Digestion 1993; 54 (Suppl. 2): 15-20.